Why the study?
Does pentoxifylline improve left ventricular function and reduce Fas/APO-1 plasma concentrations in patients with idiopathic dilated cardiomyopathy?
Does pentoxifylline improve left ventricular function and reduce Fas/APO-1 plasma concentrations in patients with idiopathic dilated cardiomyopathy?
Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline
No takes yet. Share an insight, caveat, or question.
David J. Hetmanski (2000) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: